REQUEST A DEMO
Total
USD $0.00
Search more companies

Suma Pharmaceuticals Private Limited (India)

Main Activities: Iron and Steel Mills and Ferroalloy Manufacturing
Full name: Suma Pharmaceuticals Private Limited Profile Updated: April 02, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Suma Pharmaceuticals Private Limited is an enterprise located in India, with the main office in Thane. The company operates in the Iron and Steel Mills and Ferroalloy Manufacturing industry. Suma Pharmaceuticals Private Limited was incorporated on August 06, 1991. There are currently 17 (2024) people employed by Suma Pharmaceuticals Private Limited. The latest financial highlights indicate a net sales revenue increase of 8.19% in 2024. A growth of 14.26% was recorded in its total assets.

Legal Address
Plot No.126, Chikhloli, Midc New Bhendipada
Thane; Maharashtra; Postal Code: 421501

Contact Details: Purchase the Suma Pharmaceuticals Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Suma Pharmaceuticals Private Limited report to view the information.
Registered Capital:
Purchase the Suma Pharmaceuticals Private Limited report to view the information.
Financial Auditors:
Purchase the Suma Pharmaceuticals Private Limited report to view the information.
Incorporation Date:
August 06, 1991
Key Executives
Purchase this report to view the information.
Independent Director
Purchase this report to view the information.
Independent Director
Company Performance
Financial values in the chart are available after Suma Pharmaceuticals Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
8.19%
Total Operating Revenue
8.65%
Operating Profit
84.83%
EBITDA
90.06%
Net Profit/Loss for the Period
N/A
Total Assets
14.26%
Total Equity
-14%
Operating Profit Margin
5.57%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt / Equity
331.79%
Quick Ratio
-0.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?